Sanofi (SNYNF)
| Previous close | 99.00 |
| Open | 97.91 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 97.51 - 97.91 |
| 52-week range | 88.75 - 112.65 |
| Volume | 6,873 |
| Avg. volume | 9,072 |
| Market cap | 122.396B |
| Beta (5Y monthly) | 0.41 |
| PE ratio (TTM) | 18.16 |
| EPS (TTM) | 5.37 |
| Earnings date | N/A |
| Forward dividend & yield | 3.86 (3.90%) |
| Ex-dividend date | 05 May 2021 |
| 1y target est | N/A |
- Editor's pickYahoo Finance Video
Pfizer says vaccine is 90.7% effective in kids aged 5 to 11: BBG
Dr. Calvin Sun, The Monsoon Diaries Founder & CEO, Clinical Assistant Professor and Attending Physician in Emergency Medicine in NYC, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
- GlobeNewswire
Dupixent® (dupilumab) is the first biologic to significantly reduce itch and skin lesions in Phase 3 trial for prurigo nodularis, demonstrating the role of type 2 inflammation in this disease
Dupixent® (dupilumab) is the first biologic to significantly reduce itch and skin lesions in Phase 3 trial for prurigo nodularis, demonstrating the role of type 2 inflammation in this disease Pivotal trial met primary and all key secondary endpointsDupixent significantly reduced itch at 12 weeks, and nearly three times as many Dupixent patients experienced reductions in both itch and skin lesions at 24 weeksData reinforce impact of targeting IL-4 and IL-13, key and central drivers of type 2 infl
- GlobeNewswire
FDA expands approval of Dupixent® (dupilumab) to include children aged 6 to 11 years with moderate-to-severe asthma
FDA expands approval of Dupixent® (dupilumab) to include children aged 6 to 11 years with moderate-to-severe asthma Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting potential as a best-in-class option Only biologic medicine approved for children with oral corticosteroid-dependent asthmaData reinforce well-established safety profile of Dupixent PARIS and TARRYTOWN, N.Y. – October 20, 2021 - The U.S. Food and D
